Managed Health Care Connect February 9, 2018
Eileen Koutnik-Fotopoulos

One year ago, the FDA released the health care economic information (HCEI) draft guidance on approved communication between pharmaceutical manufacturers and health care decision-makers, including payers, formulary committees, or similar entities. First Report Managed Care spoke with stakeholders for their insights and experiences on why access to HCEI is critical to better care for patients, how the guidance has impacted payers, why it is important to continue incorporating HCEI into decision making while waiting for FDA to finalize the guidelines, and where industry stands on HCEI a year later.

The Value of Access

HCEI, which is part of the 21st Century Cures Act, is an important consideration during the formulary decision-making process, according to Jay Jackson, PharmD, MPH, senior vice...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Cures Act, FDA, Payer
Why FDA Commissioner Robert Califf is 'concerned' about the incoming administration
A flurry of health tech deals announced ahead of JPM
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
FDA offers new draft guidance to developers of AI-enabled medical devices
Chevron’s Fall And Its Impact On Medical AI

Share This Article